Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system

The SARS-CoV-2 coronavirus expresses two essential proteases: firstly, the 3Chymotrypsin-like protease (3CLpro) or main protease (Mpro), and secondly, the papain-like protease (PLpro), both of which are considered as viable drug targets for the inhibition of viral replication. In order to perform dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Rafida Razali, Vijay Kumar Subbiah, Cahyo Budiman
Format: Article
Language:English
English
Published: MDPI AG 2021
Subjects:
Online Access:https://eprints.ums.edu.my/id/eprint/31419/1/Technical%20data%20of%20heterologous%20expression%20and%20purification%20of%20SARS-CoV-2%20proteases%20using%20escherichia%20coli%20system.pdf
https://eprints.ums.edu.my/id/eprint/31419/2/Technical%20data%20of%20heterologous%20expression%20and%20purification%20of%20SARS-CoV-2%20proteases%20using%20escherichia%20coli%20system_ABSTRACT.pdf
https://eprints.ums.edu.my/id/eprint/31419/
https://www.mdpi.com/2306-5729/6/9/99/htm
https://doi.org/10.3390/data6090099
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.ums.eprints.31419
record_format eprints
spelling my.ums.eprints.314192021-12-13T07:32:57Z https://eprints.ums.edu.my/id/eprint/31419/ Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system Rafida Razali Vijay Kumar Subbiah Cahyo Budiman QR355-502 Virology The SARS-CoV-2 coronavirus expresses two essential proteases: firstly, the 3Chymotrypsin-like protease (3CLpro) or main protease (Mpro), and secondly, the papain-like protease (PLpro), both of which are considered as viable drug targets for the inhibition of viral replication. In order to perform drug discovery assays for SARS-CoV-2, it is imperative that efficient methods are established for the production and purification of 3CLpro and PLpro of SARS-CoV-2, designated as 3CLpro-CoV2 and PLpro-CoV2, respectively. This article expands the data collected in the attempts to express SARS-CoV-2 proteases under different conditions and purify them under single-step chromatography. Data showed that the use of E. coli BL21(DE3) strain was sufficient to express 3CLpro-CoV2 in a fully soluble form. Nevertheless, the single affinity chromatography step was only applicable for 3CLpro-CoV2 expressed at 18 °C, with a yield and purification fold of 92% and 49, respectively. Meanwhile, PLpro-CoV2 was successfully expressed in a fully soluble form in either BL21(DE3) or BL21-CodonPlus(DE3) strains. In contrast, the single affinity chromatography step was only applicable for PLpro-CoV2 expressed using E. coli BL21-CodonPlus(DE3) at 18 or 37 °C, with a yield and purification fold of 86% (18 °C) or 83.36% (37 °C) and 112 (18 °C) or 71 (37 °C), respectively. The findings provide a guide for optimizing the production of SARS-CoV-2 proteases of E. coli host cells. MDPI AG 2021 Article PeerReviewed text en https://eprints.ums.edu.my/id/eprint/31419/1/Technical%20data%20of%20heterologous%20expression%20and%20purification%20of%20SARS-CoV-2%20proteases%20using%20escherichia%20coli%20system.pdf text en https://eprints.ums.edu.my/id/eprint/31419/2/Technical%20data%20of%20heterologous%20expression%20and%20purification%20of%20SARS-CoV-2%20proteases%20using%20escherichia%20coli%20system_ABSTRACT.pdf Rafida Razali and Vijay Kumar Subbiah and Cahyo Budiman (2021) Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system. Data, 6. pp. 1-12. ISSN 2306-5729 https://www.mdpi.com/2306-5729/6/9/99/htm https://doi.org/10.3390/data6090099
institution Universiti Malaysia Sabah
building UMS Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaysia Sabah
content_source UMS Institutional Repository
url_provider http://eprints.ums.edu.my/
language English
English
topic QR355-502 Virology
spellingShingle QR355-502 Virology
Rafida Razali
Vijay Kumar Subbiah
Cahyo Budiman
Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system
description The SARS-CoV-2 coronavirus expresses two essential proteases: firstly, the 3Chymotrypsin-like protease (3CLpro) or main protease (Mpro), and secondly, the papain-like protease (PLpro), both of which are considered as viable drug targets for the inhibition of viral replication. In order to perform drug discovery assays for SARS-CoV-2, it is imperative that efficient methods are established for the production and purification of 3CLpro and PLpro of SARS-CoV-2, designated as 3CLpro-CoV2 and PLpro-CoV2, respectively. This article expands the data collected in the attempts to express SARS-CoV-2 proteases under different conditions and purify them under single-step chromatography. Data showed that the use of E. coli BL21(DE3) strain was sufficient to express 3CLpro-CoV2 in a fully soluble form. Nevertheless, the single affinity chromatography step was only applicable for 3CLpro-CoV2 expressed at 18 °C, with a yield and purification fold of 92% and 49, respectively. Meanwhile, PLpro-CoV2 was successfully expressed in a fully soluble form in either BL21(DE3) or BL21-CodonPlus(DE3) strains. In contrast, the single affinity chromatography step was only applicable for PLpro-CoV2 expressed using E. coli BL21-CodonPlus(DE3) at 18 or 37 °C, with a yield and purification fold of 86% (18 °C) or 83.36% (37 °C) and 112 (18 °C) or 71 (37 °C), respectively. The findings provide a guide for optimizing the production of SARS-CoV-2 proteases of E. coli host cells.
format Article
author Rafida Razali
Vijay Kumar Subbiah
Cahyo Budiman
author_facet Rafida Razali
Vijay Kumar Subbiah
Cahyo Budiman
author_sort Rafida Razali
title Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system
title_short Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system
title_full Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system
title_fullStr Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system
title_full_unstemmed Technical data of heterologous expression and purification of SARS-CoV-2 proteases using escherichia coli system
title_sort technical data of heterologous expression and purification of sars-cov-2 proteases using escherichia coli system
publisher MDPI AG
publishDate 2021
url https://eprints.ums.edu.my/id/eprint/31419/1/Technical%20data%20of%20heterologous%20expression%20and%20purification%20of%20SARS-CoV-2%20proteases%20using%20escherichia%20coli%20system.pdf
https://eprints.ums.edu.my/id/eprint/31419/2/Technical%20data%20of%20heterologous%20expression%20and%20purification%20of%20SARS-CoV-2%20proteases%20using%20escherichia%20coli%20system_ABSTRACT.pdf
https://eprints.ums.edu.my/id/eprint/31419/
https://www.mdpi.com/2306-5729/6/9/99/htm
https://doi.org/10.3390/data6090099
_version_ 1760230891132551168
score 13.160551